Table 2. Prevalence of Metabolic Abnormalitiesa in PCOS Women with and without MS.
| Metabolic abnormalities | Total (n=318) | PCOS with MS (n=33) | PCOS without MS (n=285) | P valueb |
|---|---|---|---|---|
| WC ≥80 cm | 66 (20.8) | 28 (84.8) | 38 (13.3) | <0.01 |
| TG ≥1.7 mmol/L | 65 (20.4) | 26 (78.8) | 39 (13.7) | <0.01 |
| HDL-C <1.29 mmol/L | 137 (43.1) | 31 (93.9) | 106 (37.2) | <0.01 |
| BP ≥130/85 mm Hg | 18 (5.7) | 6 (18.2) | 12 (4.2) | <0.01 |
| Fasting glucose ≥5.6 mmol/L | 43 (13.5) | 18 (54.5) | 25 (8.8) | <0.01 |
| Presence of metabolic abnormalities | ||||
| 0 | 121 (38.1) | NA | 121 (42.5) | |
| 1 | 108 (34.0) | NA | 108 (37.9) | |
| 2 | 56 (17.6) | NA | 56 (19.6) | |
| 3 | 23 (7.2) | 23 (69.7) | NA | |
| 4 | 10 (3.1) | 10 (30.3) | NA | |
| 5 | 0 | 0 | NA |
Values are expressed as number (%).
PCOS, polycystic ovary syndrome; MS, metabolic syndrome; WC, waist circumference; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; BP, blood pressure; NA, not applicable.
aBased on the Adult Treatment Panel III 2005 criteria [17]; bComparison was performed between PCOS women with and without MS using the chi-square test with asymptotic significance (2-sided) for continuity correction.